Immutep's TACTI-002 Data to Be Presented at Society for Immunotherapy of Cancer 2020 Annual MeetingGlobeNewsWire • 11/02/20
Immutep to Collaborate with LabCorp to Develop Oncology Services and ProductsGlobeNewsWire • 10/29/20
Immutep Announces the Start of an Investigator-Initiated Phase II Study in COVID-19 PatientsGlobeNewsWire • 10/23/20
Immutep to Present AIPAC Overall Survival Data at the San Antonio Breast Cancer Symposium 2020GlobeNewsWire • 10/19/20
Immutep Reports Supportive Efficacy Data from the Phase IIb AIPAC Study; Overall Survival Data Expected in Late 2020GlobeNewsWire • 03/25/20
Immutep’s Partner, EOC Pharma, Reports Completion of Recruitment of Phase I Study of EftiGlobeNewsWire • 03/20/20